secwatch.observer — SEC 8-K summary
======================================

Issuer:     COMPASS Pathways plc (CMPS)
CIK:        0001816590
Form:       8-K
Filed at:   2023-09-18T23:59:59+00:00
Accession:  0001816590-23-000123
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

COMPASS Pathways appoints Daphne Karydas to Board of Directors
--------------------------------------------------------------

- Appointment effective September 18, 2023; Karydas is President/CFO of Flare Therapeutics.
- Received initial option for 52,000 ordinary shares (or ADSs) vesting over three years.
- Annual cash retainers: $40,000 as director, $8,000 as audit/risk committee member.
- Serves as Class III director; brings over 20 years biopharma financial and strategy experience.
- No family relationships with directors/officers; no material transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816590/000181659023000123/0001816590-23-000123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816590/000181659023000123/cmps-20230913.htm
  HTML page:      https://secwatch.observer/filing/0001816590-23-000123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer